
NASDAQIndustrialsIntegrated Freight & Logistics
Latest quote
$2.28
+$0.02 · +0.88%
Callan JMB Inc., operating primarily through its subsidiary Coldchain Technology Services, LLC, specializes in providing temperature-controlled logistics solutions specifically for the life sciences sector. The company's services include comprehensive frozen shipping capabilities essential for a wide range of sensitive biological and medical materials. These critical shipments encompass items such as personalized medicines, cell-based therapies, stem cells, cell lines, vaccines, diagnostic samples, reproductive materials (including semen, eggs, and embryos), cord blood, organs, biopharmaceutical products, infectious substances, and other vital commodities. Additionally, Callan JMB Inc. offers packaging services for other perishable (non-pharmaceutical) client goods, alongside technical support. The company was founded in 2006 and is based in Spring Branch, Texas.
Previous close
$2.28
+$0.02 · +0.88%
After-hours
$2.26
−$0.02 · -0.88%
Oct 9, 7:30 PM ET
Regular session · ET · Market data may be delayed.
Callan JMB Inc., operating primarily through its subsidiary Coldchain Technology Services, LLC, specializes in providing temperature-controlled logistics solutions specifically for the life sciences sector. The company's services include comprehensive frozen shipping capabilities essential for a wide range of sensitive biological and medical materials. These critical shipments encompass items such as personalized medicines, cell-based therapies, stem cells, cell lines, vaccines, diagnostic samples, reproductive materials (including semen, eggs, and embryos), cord blood, organs, biopharmaceutical products, infectious substances, and other vital commodities. Additionally, Callan JMB Inc. offers packaging services for other perishable (non-pharmaceutical) client goods, alongside technical support. The company was founded in 2006 and is based in Spring Branch, Texas.
Day range
Current $2.28
52-week range
Current $2.28
Regular session · ET · Market data may be delayed.
GoAI Score
Sell
Valuation
47
Fair Value
Sentiment
51
Mixed
Risk
66
High Risk
Momentum
20
Strong Down
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Callan JMB Inc., operating primarily through its subsidiary Coldchain Technology Services, LLC, specializes in providing temperature-controlled logistics solutions specifically for the life sciences sector. The company's services include comprehensive frozen shipping capabilities essential for a wide range of sensitive biological and medical materials. These critical shipments encompass items such as personalized medicines, cell-based therapies, stem cells, cell lines, vaccines, diagnostic samples, reproductive materials (including semen, eggs, and embryos), cord blood, organs, biopharmaceutical products, infectious substances, and other vital commodities. Additionally, Callan JMB Inc. offers packaging services for other perishable (non-pharmaceutical) client goods, alongside technical support. The company was founded in 2006 and is based in Spring Branch, Texas.
Day range
Current $2.28
52-week range
Current $2.28
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 5.72M USD | 6.56M USD | 13.2M USD | 22.77M USD |
| Cost of goods sold | 3.62M USD | 4M USD | 7.55M USD | 13.32M USD |
| Gross profit | 2.1M USD | 2.56M USD | 5.65M USD | 9.45M USD |
| Selling, general, and administrative | 8.6M USD | 4.64M USD | 3.33M USD | 3.15M USD |
| Operating expenses | 8.6M USD | 4.84M USD | 3.45M USD | 3.15M USD |
| Interest income | 8.69K USD | 11.9K USD | 2.05K USD | — |
| Interest expense | 2.68K USD | 5.37K USD | — | 6.12K USD |
| Depreciation and amortization | 151.95K USD | 143.69K USD | 102.8K USD | 68.49K USD |
| Operating income | −6.49M USD | −2.27M USD | 2.2M USD | 6.3M USD |
| Net income | −7.97M USD | −2.29M USD | 2.18M USD | 6.22M USD |
Company facts updated Oct 10, 2026.
Recent quarterly results
Recent quarterly results
Funds reporting this stock among their holdings, ordered by reported position size.
AI-generated and delayed market data for informational and educational purposes only. Not investment advice.